1. Home
  2. TLS vs PRQR Comparison

TLS vs PRQR Comparison

Compare TLS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$5.12

Market Cap

463.8M

Sector

Technology

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.99

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
PRQR
Founded
1969
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
250.7M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
TLS
PRQR
Price
$5.12
$1.99
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$7.75
$8.14
AVG Volume (30 Days)
1.0M
658.1K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$144,400,000.00
$18,859,556.00
Revenue This Year
$52.27
N/A
Revenue Next Year
$20.44
$19.56
P/E Ratio
N/A
N/A
Revenue Growth
17.44
N/A
52 Week Low
$1.83
$1.07
52 Week High
$8.36
$3.10

Technical Indicators

Market Signals
Indicator
TLS
PRQR
Relative Strength Index (RSI) 38.00 40.51
Support Level $4.97 $2.03
Resistance Level $5.22 $2.31
Average True Range (ATR) 0.31 0.17
MACD -0.01 -0.02
Stochastic Oscillator 9.80 13.04

Price Performance

Historical Comparison
TLS
PRQR

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: